Capricor Therapeutics's total assets for Q4 2023 were $58.73M, an increase of 58.09% from the previous quarter. CAPR total liabilities were $36.13M for the fiscal quarter, a -7.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.